Point72 Asset Management’s Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share HIPO.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding HIPO.WS
CAC
SPC
KL
SRF
GS
LCG
EPM
Point72 Asset Management's HIPO.WS Position: Q1 2024 in Review
Point72 Asset Management sold out of Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share (HIPO.WS) in Q1 2024, closing a stake of 12,000 shares — an estimated $240 sold.
Point72 Asset Management first reported a position in HIPO.WS in Q3 2021 and held it in 10 quarters. The position peaked at $11K in Q3 2021. 18 funds tracked by Wall St. Rank hold HIPO.WS as of Q1 2024.
- Point72 Asset Management reported no remaining Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position as of Q1 2024 after selling out during the quarter.
- Point72 Asset Management sold 12,000 Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share shares in Q1 2024, an estimated $240.
- Point72 Asset Management first reported a position in Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share in Q3 2021 and held it in 10 quarters.
- Point72 Asset Management's Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position peaked at $11K in Q3 2021.
- 18 funds tracked by Wall St. Rank held Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share as of Q1 2024.
Based on Point72 Asset Management's 13F filing for Q1 2024, filed 15 May 2024.